Publisher
Springer Science and Business Media LLC
Reference25 articles.
1. Ferlay, J., I. Soerjomataram, R. Dikshit, S. Eser, C. Mathers, M. Rebelo, D.M. Parkin, D. Forman, and F. Bray, Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. International journal of cancer, 2015. 136(5).
2. Noone AM, H.N., Krapcho M, Miller D, Brest A, Yu M, Ruhl J, Tatalovich Z, Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA (eds). SEER Cancer Statistics Review, 1975–2015. Available from:
https://seer.cancer.gov/csr/1975_2015/
, based on November 2017 SEER data submission, posted to the SEER web site, April 2018.
3. Arnold, M., M. Laversanne, L.M. Brown, S.S. Devesa, and F. Bray, Predicting the future burden of esophageal cancer by histological subtype: international trends in incidence up to 2030. The American journal of gastroenterology, 2017. 112(8): p. 1247.
4. Little, A.G., A.E. Lerut, D.H. Harpole, W.L. Hofstetter, J.D. Mitchell, N.K. Altorki, and M.J. Krasna, The Society of Thoracic Surgeons practice guidelines on the role of multimodality treatment for cancer of the esophagus and gastroesophageal junction. The Annals of Thoracic Surgery, 2014. 98(5): p. 1880–1885.
5. Tepper, J., M.J. Krasna, D. Niedzwiecki, D. Hollis, C.E. Reed, R. Goldberg, K. Kiel, C. Willett, D. Sugarbaker, and R. Mayer, Phase III trial of trimodality therapy with cisplatin, fluorouracil, radiotherapy, and surgery compared with surgery alone for esophageal cancer: CALGB 9781. Journal of clinical oncology: official journal of the American Society of Clinical Oncology, 2008. 26(7): p. 1086.
Cited by
20 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献